Skip to content
HowShorted

Beam Therapeutics Inc. short interest in 2021

In 2021, Beam Therapeutics Inc.'s disclosed short interest ran from 9.54% of shares outstanding on 15 Jan 2021 to 8.18% on 31 Dec 2021, a change of -1.36 percentage points. The year's high was 11.20% on 15 Apr 2021 and its low 7.05% on 29 Oct 2021, averaging 9.01% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.46 days on 29 Oct 2021. Full history: Beam Therapeutics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Beam Therapeutics Inc. in 2021

2021 in figures

Start of year
9.54% (15 Jan 2021)
End of year
8.18% (31 Dec 2021)
Change
-1.36 pp
High
11.20% (15 Apr 2021)
Low
7.05% (29 Oct 2021)
Average
9.01%
Highest days to cover
14.46 (29 Oct 2021)
SEC filings marked
8

Every report in 2021

Beam Therapeutics Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20219.54%6.86
29 Jan 20219.63%4.63
12 Feb 20219.21%6.50
26 Feb 20219.97%4.86
15 Mar 202110.85%5.5210-K filed, results (8-K)
31 Mar 202110.88%7.39
15 Apr 202111.20%8.27
30 Apr 202110.55%10.62
14 May 202111.04%6.8010-Q filed, results (8-K)
28 May 202110.59%10.74
15 Jun 202110.37%12.48
30 Jun 20218.55%3.95
15 Jul 20217.78%4.55
30 Jul 20218.05%9.70
13 Aug 20217.78%7.4510-Q filed, results (8-K)
31 Aug 20218.33%9.77
15 Sep 20217.87%7.76
30 Sep 20217.60%6.30
15 Oct 20218.31%8.41
29 Oct 20217.05%14.46
15 Nov 20217.12%9.7610-Q filed, results (8-K)
30 Nov 20217.67%8.08
15 Dec 20218.09%8.00
31 Dec 20218.18%10.06

See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.